ArticleTobacco induced diseases2026
Smoking cessation, weight change, and incidence and progression of frailty: A longitudinal analysis of the US Health and Retirement Study.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSmoking cessation is important for healthy ageing, but accompanying weight change may influence subsequent functional vulnerability. We examined whether attained cessation duration and weight change across the observed cessation interval distinguished later frailty risk and frailty-index progression.
methodsThis longitudinal secondary analysis included 27020 Health and Retirement Study participants with self-reported smoking and body-weight data, and valid consecutive frailty assessments who were non-frail at risk-set entry during 1998-2020. Smoking status, body weight, and covariates were assessed biennially by structured interviews. Time-varying Cox models estimated incident frailty (frailty index ≥0.25), mixed-effects models assessed annual frailty-index change, and restricted cubic splines evaluated continuous associations.
resultsOver a median follow-up of 8.1 years, 10641 incident frailty cases occurred during 250439.9 person-years. Compared with current smokers, quitters before baseline had lower frailty risk (hazard ratio, HR=0.79; 95% CI: 0.75-0.84), whereas follow-up quitters overall did not (HR=0.98; 95% CI: 0.90-1.07). In the duration spline, HRs at 0, 7, and 10 years of attained cessation duration were 1.14 (95% CI: 1.01-1.28), 0.79 (95% CI: 0.67-0.93), and 0.73 (95% CI: 0.60-0.89), respectively. Among follow-up quitters, >10.0 kg versus 0.1-5.0 kg weight gain was associated with higher risk (HR=1.94; 95% CI: 1.44-2.61); standardized 2-year risks among eligible analytic intervals were 15.9% and 9.5%, respectively. The direct progression contrast was imprecise in Model 3 and was estimated at β=0.415 (95% CI: 0.040-0.790; p=0.030) after additional adjustment for interval-start frailty index.
conclusionsLonger cessation duration was associated with lower frailty risk. Substantial weight gain across the observed cessation interval was associated with higher absolute frailty risk among follow-up quitters. Smoking cessation remains the priority, but marked gain may help identify quitters who warrant continued weight and functional monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.